Profiling lung adenocarcinoma by liquid biopsy: can one size fit all?

BACKGROUND: Cancer is first and foremost a disease of the genome. Specific genetic signatures within a tumour are prognostic of disease outcome, reflect subclonal architecture and intratumour heterogeneity, inform treatment choices and predict the emergence of resistance to targeted therapies. Minim...

Descripción completa

Detalles Bibliográficos
Autores principales: Clifford, Harry W., Cassidy, Amy P., Vaughn, Courtney, Tsai, Evaline S., Seres, Bianka, Patel, Nirmesh, O’Neill, Hannah L., Hewage, Emil, Cassidy, John W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119837/
https://www.ncbi.nlm.nih.gov/pubmed/27933110
http://dx.doi.org/10.1186/s12645-016-0023-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5119837/
https://www.ncbi.nlm.nih.gov/pubmed/27933110
http://dx.doi.org/10.1186/s12645-016-0023-8

Ejemplares similares